Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Gerlinger

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Journal of Patient-Reported Outcomes|February 20, 2020
Development and content validation of two new patient-reported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)Adam Gater, Fiona Taylor, Christian Seitz, et al.
Health and Quality of Life Outcomes|November 26, 2010
Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trialsChristoph Gerlinger, Ulrike Schumacher, Thomas Faustmann, et al.
BMC Women'S Health|August 22, 2012
Estimation of menstrual blood loss volume based on menstrual diary and laboratory dataUlrike Schumacher, Jens Schumacher, Uwe Mellinger, et al.
Journal of Patient-Reported Outcomes|June 11, 2025
Psychometric validation of the severity of chronic cough diary, leicester cough questionnaire, and a cough severity visual analogue scale in patients with refractory chronic coughAndrew Trigg, Nathan Clarke, Christoph Gerlinger, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 13, 2009
A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosisGünter Köhler, Thomas A Faustmann, Christoph Gerlinger, et al.
The British Journal of Radiology|September 23, 2024
Does the risk of hypersensitivity reactions to iopromide differ by sex, race, or across regions/countries? An analysis of 152 233 patients from 4 observational studies and the company's pharmacovigilance databaseJan Endrikat, Alexander Ullmann, Christoph Gerlinger, et al.
Menopause (New York, N.Y.)|August 22, 2013
Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptomsGabriele Sutter, Thomas Schmelter, Kerstin Gude, et al.
Clinical Drug Investigation|April 14, 2010
Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre studySue Kelly, Emyr Davies, Simon Fearns, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|March 22, 2020
Cervical and Lower Uterine Parameter Ultrasound and Elastographic Parameters for the Prediction of a Successful Induction of LaborAmr Hamza, Julia Radosa, Christoph Gerlinger, et al.
Investigative Radiology|December 3, 2021
Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly: An Analysis of 132,850 Patients From 4 Observational Studies and Pharmacovigilance Covering >288 Million AdministrationsJan Endrikat, Julia Chernova, Christoph Gerlinger, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Journal of Patient-Reported Outcomes|February 20, 2020
Development and content validation of two new patient-reported outcome measures for endometriosis: the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)Adam Gater, Fiona Taylor, Christian Seitz, et al.
Health and Quality of Life Outcomes|November 26, 2010
Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trialsChristoph Gerlinger, Ulrike Schumacher, Thomas Faustmann, et al.
BMC Women'S Health|August 22, 2012
Estimation of menstrual blood loss volume based on menstrual diary and laboratory dataUlrike Schumacher, Jens Schumacher, Uwe Mellinger, et al.
Journal of Patient-Reported Outcomes|June 11, 2025
Psychometric validation of the severity of chronic cough diary, leicester cough questionnaire, and a cough severity visual analogue scale in patients with refractory chronic coughAndrew Trigg, Nathan Clarke, Christoph Gerlinger, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 13, 2009
A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosisGünter Köhler, Thomas A Faustmann, Christoph Gerlinger, et al.
The British Journal of Radiology|September 23, 2024
Does the risk of hypersensitivity reactions to iopromide differ by sex, race, or across regions/countries? An analysis of 152 233 patients from 4 observational studies and the company's pharmacovigilance databaseJan Endrikat, Alexander Ullmann, Christoph Gerlinger, et al.
Menopause (New York, N.Y.)|August 22, 2013
Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17β-estradiol in postmenopausal women with moderate to severe vasomotor symptomsGabriele Sutter, Thomas Schmelter, Kerstin Gude, et al.
Clinical Drug Investigation|April 14, 2010
Effects of oral contraceptives containing ethinylestradiol with either drospirenone or levonorgestrel on various parameters associated with well-being in healthy women: a randomized, single-blind, parallel-group, multicentre studySue Kelly, Emyr Davies, Simon Fearns, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|March 22, 2020
Cervical and Lower Uterine Parameter Ultrasound and Elastographic Parameters for the Prediction of a Successful Induction of LaborAmr Hamza, Julia Radosa, Christoph Gerlinger, et al.
Investigative Radiology|December 3, 2021
Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly: An Analysis of 132,850 Patients From 4 Observational Studies and Pharmacovigilance Covering >288 Million AdministrationsJan Endrikat, Julia Chernova, Christoph Gerlinger, et al.
Pageof 9